Compare IMNM & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | VERX |
|---|---|---|
| Founded | 2006 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2020 | 2020 |
| Metric | IMNM | VERX |
|---|---|---|
| Price | $19.53 | $12.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $35.20 | $17.15 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,941,000.00 | ★ $748,444,000.00 |
| Revenue This Year | N/A | $10.51 |
| Revenue Next Year | $18,747.97 | $10.51 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | N/A | ★ 12.25 |
| 52 Week Low | $13.53 | $10.21 |
| 52 Week High | $30.06 | $26.54 |
| Indicator | IMNM | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 56.37 |
| Support Level | $19.39 | $12.16 |
| Resistance Level | $23.48 | $13.56 |
| Average True Range (ATR) | 1.12 | 0.47 |
| MACD | -0.27 | 0.15 |
| Stochastic Oscillator | 13.81 | 91.53 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.